Truveta Raises $320M in Series B
Truveta has successfully raised $320M in a Series B at a $1.5B valuation led by Regeneron Pharmaceuticals, Illumina.
Company Overview
Truveta is a HealthTech company headquartered in Bellevue, WA, founded in 2020 with 300+ employees.
Health data and research platform
Fundraising Details
- Amount Raised: $320M
- Round Type: Series B
- Valuation: $1.5B
- Date: 2025-01-25
- Investors: Regeneron Pharmaceuticals, Illumina
About Truveta
Health data and research platform The company is positioned in the HealthTech sector, serving a growing market with innovative solutions.
Key Information
- Headquarters: Bellevue, WA
- Founded: 2020
- Team Size: 300+
- Industry: HealthTech
What This Means
This funding round demonstrates strong investor confidence in Truveta's vision and execution. The capital will likely be used to:
- Scale Operations: Expand the team and operational capacity
- Product Development: Enhance existing products and develop new features
- Market Expansion: Enter new markets and strengthen presence in existing ones
- Technology Investment: Invest in infrastructure and technology capabilities
Industry Context
The HealthTech sector continues to attract significant investment as companies innovate to meet evolving market demands. Truveta's successful fundraising reflects the strong fundamentals and growth potential in this space.
Valuation Milestone
Reaching a $1.5B valuation marks an important milestone for Truveta, positioning the company among notable players in the HealthTech industry.
Looking Ahead
With this new capital, Truveta is well-positioned to execute on its growth strategy and continue building innovative solutions in the HealthTech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.
---
This fundraising news was reported on 2025-01-25. For more information about Truveta, visit their headquarters at Bellevue, WA.
